Case Reports
doi: 10.1016/j.jdcr.2019.02.008.
eCollection 2019 Apr.
Pembrolizumab-induced bullous pemphigoid
Affiliations
- PMID: 31008169
- PMCID: PMC6453921
- DOI: 10.1016/j.jdcr.2019.02.008
Item in Clipboard
Case Reports
Pembrolizumab-induced bullous pemphigoid
JAAD Case Rep.
.
No abstract available
Keywords: BP, bullous pemphigoid; PD-1, programmed cell death 1; bullous pemphigoid; pembrolizumab; programmed cell death 1 inhibitor.
Figures
Tense bullae on the ankle.
Tense bullae and erosions on the abdomen.
Similar articles
-
Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.Front Med (Lausanne). 2018 Sep 27;5:268. doi: 10.3389/fmed.2018.00268. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30320114 Free PMC article.
-
Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system.Expert Opin Drug Saf. 2019 Jul;18(7):623-633. doi: 10.1080/14740338.2019.1619693. Epub 2019 May 22. Expert Opin Drug Saf. 2019. PMID: 31088310
-
Development of bullous pemphigoid during nivolumab therapy.JAAD Case Rep. 2016 Dec 3;2(6):442-444. doi: 10.1016/j.jdcr.2016.05.009. eCollection 2016 Nov. JAAD Case Rep. 2016. PMID: 27981213 Free PMC article. No abstract available.
-
A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors.Int J Dermatol. 2018 Jun;57(6):664-669. doi: 10.1111/ijd.13984. Epub 2018 Apr 6. Int J Dermatol. 2018. PMID: 29630716 Review.
-
A case report of bullous pemphigoid associated with a melanoma and review of the literature.Melanoma Res. 2017 Feb;27(1):65-67. doi: 10.1097/CMR.0000000000000307. Melanoma Res. 2017. PMID: 27759577 Free PMC article. Review.
Cited by
-
Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid.Front Oncol. 2023 Mar 3;13:1095694. doi: 10.3389/fonc.2023.1095694. eCollection 2023. Front Oncol. 2023. PMID: 36937423 Free PMC article.
-
Atypical Presentation of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in a Patient on Pembrolizumab: A Case Report.Cureus. 2024 May 7;16(5):e59804. doi: 10.7759/cureus.59804. eCollection 2024 May. Cureus. 2024. PMID: 38846231 Free PMC article.
-
Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers.Front Immunol. 2021 Feb 23;11:588582. doi: 10.3389/fimmu.2020.588582. eCollection 2020. Front Immunol. 2021. PMID: 33708189 Free PMC article.
-
Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis.JAAD Case Rep. 2020 Apr 29;6(5):400-402. doi: 10.1016/j.jdcr.2020.03.003. eCollection 2020 May. JAAD Case Rep. 2020. PMID: 32382629 Free PMC article. No abstract available.
-
Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation.Dermatopathology (Basel). 2022 Mar 18;9(1):60-81. doi: 10.3390/dermatopathology9010010. Dermatopathology (Basel). 2022. PMID: 35323203 Free PMC article.
References
-
- Nishie W. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. J Dermatol Sci. 2014;73:179–186. - PubMed
-
- Smith E.P., Taylor T.B., Meyer L.J., Zone J.J. Antigen identification in drug-induced bullous pemphigoid. J Am Acad Dermatol. 1993;29:879–882. - PubMed
-
- Stavropoulos P.G., Soura E., Antonious C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28:1133–1140. - PubMed
Publication types
LinkOut - more resources
Full Text Sources